View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Halozyme Therapeutics Inc: 1 director

A director at Halozyme Therapeutics Inc sold 20,000 shares at 50.315USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

Pierre FerraguÊ
  • Pierre FerraguÊ

Will Apple Intelligence ever be street-smart?

We listened to Apple’s keynote yesterday and brainstormed it as a team. You’ll find in this note our early thoughts. As the title portrays well, we have tried to be as thought provoking and irreverent as possible in this write-up. This is in our experience the best way to stimulate a healthy and independent thinking process. We probably bring more questions than we answer, as figuring out where all this will lead us is still a work in progress.

Daniel Ives ... (+6)
  • Daniel Ives
  • John Katsingris
  • Michael Gerbino
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig
Wedbush Research
  • Wedbush Research
Daniel Ives ... (+6)
  • Daniel Ives
  • John Katsingris
  • Michael Gerbino
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch